{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:04:10Z","timestamp":1778605450866,"version":"3.51.4"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The aim of this study is to improve the water solubility and stability of cannabidiol\n(CBD) utilizing micelle technology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>Mixing of rubusoside (RUB) with Poloxamer 407 (P407) was explored as the\nwall material for the preparation of CBD micelles. In this study, CBD-loaded mixed micelles (CBD-M)\ncomposed of P407 and RUB was successfully formed by self-assembly then solid were prepared by\nsolvent evaporation. The saturated solubility of CBD-loaded micelles in water increased to 15.60 mg\/mL,\n1560-fold compared with its intrinsic solubility (0.01 mg\/mL). The average size of CBD-M was 103 \u00b1\n2.66 nm and the encapsulation efficiency for CBD was 92.8 + 4.7 %, and 18.6 + 0.94% for drug-loading.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The morphology and encapsulation of CBD-M were characterized by TEM, FI-IR, DSC and\nTG. The CBD-M solution was stable and CBD-M did not precipitate or leak after being diluted and\ncentrifugated. Besides, CBD-M solution was stable for 6 months at 4\u00b0C and room temperature. In vitro\nantioxidant studies found that the antioxidant activity of CBD remained at the same level after micellization.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These results suggest that CBD-M may be a promising and competitive formulation for the\ndelivery of CBD, laying a foundation for improving the bioavailability in the future.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201820666230330090025","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T23:58:30Z","timestamp":1680220710000},"page":"271-282","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Solubility Enhancement and Antioxidation Maintenance of CBD Encapsulated\nin the P407-RUB Nano-micelle System"],"prefix":"10.2174","volume":"21","author":[{"given":"Yan-Ting","family":"Su","sequence":"first","affiliation":[{"name":"School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, 200418, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, 200418, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2019.03.014","volume":"96","author":"Samanta D.","year":"2019","unstructured":"Samanta D.; Cannabidiol: A review of clinical efficacy and safety in epilepsy. Pediatr Neurol 2019,96,24-29","journal-title":"Pediatr Neurol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","volume":"12","author":"Blessing E.M.","year":"2015","unstructured":"Blessing E.M.; Steenkamp M.M.; Manzanares J.; Marmar C.R.; Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics 2015,12(4),825-836","journal-title":"Neurotherapeutics"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1017\/S2045796018000239","volume":"27","author":"Mandolini G.M.","year":"2018","unstructured":"Mandolini G.M.; Lazzaretti M.; Pigoni A.; Oldani L.; Delvecchio G.; Brambilla P.; Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiol Psychiatr Sci 2018,27(4),327-335","journal-title":"Epidemiol Psychiatr Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.bpa.2020.06.004","volume":"34","author":"Urits I.","year":"2020","unstructured":"Urits I.; Gress K.; Charipova K.; Habib K.; Lee D.; Lee C.; Jung J.W.; Kassem H.; Cornett E.; Paladini A.; Varrassi G.; Kaye A.D.; Viswanath O.; Use of cannabidiol (CBD) for the treatment of chronic pain. Baillieres Best Pract Res Clin Anaesthesiol 2020,34(3),463-477","journal-title":"Baillieres Best Pract Res Clin Anaesthesiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00228-012-1441-0","volume":"69","author":"Stott C.G.","year":"2013","unstructured":"Stott C.G.; White L.; Wright S.; Wilbraham D.; Guy G.W.; A phase I study to assess the single and multiple dose pharmacokinetics of THC\/CBD oromucosal spray. Eur J Clin Pharmacol 2013,69(5),1135-1147","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ptr.2625","volume":"23","author":"Scuderi C.","year":"2009","unstructured":"Scuderi C.; Filippis D.D.; Iuvone T.; Blasio A.; Steardo A.; Esposito G.; Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders. Phytother Res 2009,23(5),597-602","journal-title":"Phytother Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s11689-019-9277-x","volume":"11","author":"Heussler H.","year":"2019","unstructured":"Heussler H.; Cohen J.; Silove N.; Tich N.; Bonn-Miller M.O.; Du W.; O\u2019Neill C.; Sebree T.; A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome. J Neurodev Disord 2019,11(1),16","journal-title":"J Neurodev Disord"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/glia.23738","volume":"68","author":"dos-Santos-Pereira M.","year":"2020","unstructured":"dos-Santos-Pereira M.; Guimar\u00e3es F.S.; Del-Bel E.; Raisman-Vozari R.; Michel P.P.; Cannabidiol prevents LPS\u2010induced microglial inflammation by inhibiting ROS\/NF\u2010\u03baB\u2010dependent signaling and glucose consumption. Glia 2020,68(3),561-573","journal-title":"Glia"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"Atalay S.","year":"2019","unstructured":"Atalay S.; Jarocka-Karpowicz I.; Skrzydlewska E.; Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants 2019,9(1),21","journal-title":"Antioxidants"},{"key":"ref=10","first-page":"122-130","author":"Borges R.S.","year":"2017","unstructured":"Borges R.S.; da Silva A.B.F.; Cannabidiol as an Antioxidant. Handbook of Cannabis and Related Pathologies 2017,122-130","journal-title":"Handbook of Cannabis and Related Pathologies"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","volume":"75","author":"Massi P.","year":"2013","unstructured":"Massi P.; Solinas M.; Cinquina V.; Parolaro D.; Cannabidiol as potential anticancer drug. Br J Clin Pharmacol 2013,75(2),303-312","journal-title":"Br J Clin Pharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157488611798280924","volume":"6","author":"Bergamaschi M.M.","year":"2011","unstructured":"Bergamaschi M.M.; Queiroz R.H.; Zuardi A.W.; Crippa J.A.; Safety and side effects of cannabidiol, a Cannabis sativa constituent. Curr Drug Saf 2011,6(4),237-249","journal-title":"Curr Drug Saf"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"Millar S.A.","year":"2018","unstructured":"Millar S.A.; Stone N.L.; Yates A.S.; O\u2019Sullivan S.E.; A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol 2018,9,1365","journal-title":"Front Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jconrel.2012.05.003","volume":"161","author":"Hern\u00e1n P\u00e9rez de la Ossa D.","year":"2012","unstructured":"Hern\u00e1n P\u00e9rez de la Ossa D.; Ligresti A.; Gil-Alegre M.E.; Aberturas M.R.; Molpeceres J.; Di Marzo V.; Torres Su\u00e1rez A.I.; Poly-\u03b5-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy. J Control Release 2012,161(3),927-932","journal-title":"J Control Release"},{"key":"ref=15","author":"Jason W.","unstructured":"Jason W.; Dilkushi P.; Stephanie K.;  Cannabidiol: Pre-review repotrt of expert committee on drug dependence thirty-ninth meeting. World Health Organization. Cannabidiol (CBD) pre-review report agenda item 5.2[C]. Expert Committee on Drug Dependence Thirty-ninth Meeting. 2017."},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2011.08.032","volume":"420","author":"Kawabata Y.","year":"2011","unstructured":"Kawabata Y.; Wada K.; Nakatani M.; Yamada S.; Onoue S.; Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int J Pharm 2011,420(1),1-10","journal-title":"Int J Pharm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1038\/bdj.2007.749","volume":"203","author":"Scully C.","year":"2007","unstructured":"Scully C.; Cannabis; adverse effects from an oromucosal spray. Br Dent J 2007,203(6),E12","journal-title":"Br Dent J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3390\/molecules24162967","volume":"24","author":"Knaub K.","year":"2019","unstructured":"Knaub K.; Sartorius T.; Dharsono T.; Wacker R.; Wilhelm M.; Sch\u00f6n C.; A novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb\u00ae formulation technology improving the oral bioavailability of cannabidiol in healthy subjects. Molecules 2019,24(16),2967","journal-title":"Molecules"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000497361","volume":"2","author":"Nakano Y.","year":"2019","unstructured":"Nakano Y.; Tajima M.; Sugiyama E.; Sato V.H.; Sato H.; Development of a novel nano\u00acemulsion formulation to improve intestinal absorption of cannabidiol. Med Cannabis Cannabinoids 2019,2(1),35-42","journal-title":"Med Cannabis Cannabinoids"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"116070","DOI":"10.1016\/j.molliq.2021.116070","volume":"334","author":"Li H.","year":"2021","unstructured":"Li H.; Chang S-L.; Chang T-R.; You Y.; Wang X-D.; Wang L-W.; Yuan X-F.; Tan M-H.; Wang P-D.; Xu P-W.; Gao W-B.; Zhao Q-S.; Zhao B.; Inclusion complexes of cannabidiol with \u03b2-cyclodextrin and its derivative: Physicochemical properties, water solubility, and antioxidant activity. J Mol Liq 2021,334,116070","journal-title":"J Mol Liq"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jps.20766","volume":"96","author":"Mannila J.","year":"2007","unstructured":"Mannila J.; J\u00e4rvinen T.; J\u00e4rvinen K.; Jarho P.; Precipitation complexation method produces cannabidiol\/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol. J Pharm Sci 2007,96(2),312-319","journal-title":"J Pharm Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"119812","DOI":"10.1016\/j.ijpharm.2020.119812","volume":"589","author":"Koch N.","year":"2020","unstructured":"Koch N.; Jennotte O.; Gasparrini Y.; Vandenbroucke F.; Lechanteur A.; Evrard B.; Cannabidiol aqueous solubility enhancement: Comparison of three amorphous formulations strategies using different type of polymers. Int J Pharm 2020,589,119812","journal-title":"Int J Pharm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1049\/nbt2.12018","volume":"15","author":"Bose A.","year":"2021","unstructured":"Bose A.; Roy Burman D.; Sikdar B.; Patra P.; Nanomicelles: Types, properties and applications in drug delivery. IET Nanobiotechnol 2021,15(1),19-27","journal-title":"IET Nanobiotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijpharm.2018.08.001","volume":"549","author":"Sayed S.","year":"2018","unstructured":"Sayed S.; Elsayed I.; Ismail M.M.; Optimization of \u03b2-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug. Int J Pharm 2018,549(1-2),249-260","journal-title":"Int J Pharm"},{"key":"ref=25","first-page":"1933","volume":"23","author":"Zhang H.","year":"2016","unstructured":"Zhang H.; Yang X.; Zhao L.; Jiao Y.; Liu J.; Zhai G.; In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery. Drug Deliv 2016,23(6),1933-1939","journal-title":"Drug Deliv"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CAD.0000000000000173","volume":"26","author":"Liu Z.","year":"2015","unstructured":"Liu Z.; Zhang F.; Koh G.Y.; Dong X.; Hollingsworth J.; Zhang J.; Russo P.S.; Yang P.; Stout R.W.; Cytotoxic and antiangiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles. Anticancer Drugs 2015,26(2),167-179","journal-title":"Anticancer Drugs"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1002\/jps.22512","volume":"100","author":"Zhang F.","year":"2011","unstructured":"Zhang F.; Koh G.Y.; Jeansonne D.P.; Hollingsworth J.; Russo P.S.; Vicente G.; Stout R.W.; Liu Z.; A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity. J Pharm Sci 2011,100(7),2778-2789","journal-title":"J Pharm Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ijpharm.2012.06.013","volume":"434","author":"Zhang F.","year":"2012","unstructured":"Zhang F.; Koh G.Y.; Hollingsworth J.; Russo P.S.; Stout R.W.; Liu Z.; Reformulation of etoposide with solubility-enhancing rubusoside. Int J Pharm 2012,434(1-2),453-459","journal-title":"Int J Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"nnm-2016","DOI":"10.2217\/nnm-2016-0188","volume":"11","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Chou G.; Liu Z.; Liu M.; Employing rubusoside to improve the solubility and permeability of antitumor compound betulonic acid. Nanomedicine (Lond) 2016,11(21),nnm-2016-0188","journal-title":"Nanomedicine (Lond)"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijpharm.2018.10.006","volume":"552","author":"Song K.","year":"2018","unstructured":"Song K.; Xin M.; Yu H.; Zheng Z.; Li J.; Li M.; Guo H.; Tan Y.; Wu X.; Novel ultra-small micelles based on rebaudioside A: A potential nanoplatform for ocular drug delivery. Int J Pharm 2018,552(1-2),265-276","journal-title":"Int J Pharm"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1039\/C4PY00039K","volume":"5","author":"Pitto-Barry A.","year":"2014","unstructured":"Pitto-Barry A.; Barry N.P.E.; Pluronic\u00ae block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Polym Chem 2014,5(10),3291-3297","journal-title":"Polym Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.fluid.2018.06.009","volume":"473","year":"2018","unstructured":"\u0106irin, D.; Krstono\u0161i\u0107, V.; Sazdani\u0107, D. Synergism and antagonism in mixed monolayers: Brij S20\/poloxamer 407 and Triton X-100\/poloxamer 407 mixtures. Fluid Phase Equilib 2018,473,220-225","journal-title":"Fluid Phase Equilib"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jiec.2016.11.032","volume":"47","year":"2017","unstructured":"\u0106irin, D.; Krstono\u0161i\u0107, V.; Po\u0161a, M. Properties of poloxamer 407 and polysorbate mixed micelles: Influence of polysorbate hydrophobic chain. J Ind Eng Chem 2017,47,194-201","journal-title":"J Ind Eng Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.msec.2019.03.103","volume":"101","author":"Liu X.","year":"2019","unstructured":"Liu X.; Chen Y.; Chen X.; Su J.; Huang C.; Enhanced efficacy of baicalin-loaded TPGS polymeric micelles against periodontitis. Mater Sci Eng C 2019,101,387-395","journal-title":"Mater Sci Eng C"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.3390\/molecules24193485","volume":"24","author":"Tura M.","year":"2019","unstructured":"Tura M.; Mandrioli M.; Gallina Toschi T.; Preliminary Study: Comparison of Antioxidant Activity of Cannabidiol (CBD) and \u03b1-Tocopherol Added to Refined Olive and Sunflower Oils. Molecules 2019,24(19),3485","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/md18020122","volume":"18","author":"Coulombier N.","year":"2020","unstructured":"Coulombier N.; Nicolau E.; Le D\u00e9an L.; Antheaume C.; Jauffrais T.; Lebouvier N.; Impact of light intensity on antioxidant activity of tropical microalgae. Mar Drugs 2020,18(2),122","journal-title":"Mar Drugs"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/molecules26051469","volume":"26","author":"Francke N.M.","year":"2021","unstructured":"Francke N.M.; Schneider F.; Baumann K.; Bunjes H.; Formulation of cannabidiol in colloidal lipid carriers. Molecules 2021,26(5),1469","journal-title":"Molecules"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.foodchem.2018.04.008","volume":"260","author":"Pu H.","year":"2018","unstructured":"Pu H.; Sun Q.; Tang P.; Zhao L.; Li Q.; Liu Y.; Li H.; Characterization and antioxidant activity of the complexes of tertiary butylhydroquinone with \u03b2-cyclodextrin and its derivatives. Food Chem 2018,260,183-192","journal-title":"Food Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"106402","DOI":"10.1016\/j.prostaglandins.2019.106402","volume":"146","author":"Chen J.","year":"2020","unstructured":"Chen J.; Khiste S.K.; Fu X.; Roy K.R.; Dong Y.; Zhang J.; Liu M.; Liu Y.Y.; Liu Z.; Rubusoside-assisted solubilization of poorly soluble C6-Ceramide for a pilot pharmacokinetic study. Prostagland Other Lipid Mediat 2020,146,106402","journal-title":"Prostagland Other Lipid Mediat"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/10717544.2018.1440669","volume":"25","author":"Zhang W.","year":"2018","unstructured":"Zhang W.; Li C.; Jin Y.; Liu X.; Wang Z.; Shaw J.P.; Baguley B.C.; Wu Z.; Liu J.; Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy. Drug Deliv 2018,25(1),611-622","journal-title":"Drug Deliv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.molpharmaceut.7b00939","volume":"15","author":"Grimaudo M.A.","year":"2018","unstructured":"Grimaudo M.A.; Pescina S.; Padula C.; Santi P.; Concheiro A.; Alvarez-Lorenzo C.; Nicoli S.; Poloxamer 407\/TPGS mixed micelles as promising carriers for cyclosporine ocular delivery. Mol Pharm 2018,15(2),571-584","journal-title":"Mol Pharm"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.colsurfb.2012.04.017","volume":"97","author":"Zhao L.","year":"2012","unstructured":"Zhao L.; Du J.; Duan Y.; Zang Y.; Zhang H.; Yang C.; Cao F.; Zhai G.; Curcumin loaded mixed micelles composed of Pluronic P123 and F68: Preparation, optimization and in vitro characterization. Colloids Surf B Biointerfaces 2012,97,101-108","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.colsurfb.2011.12.034","volume":"93","author":"Raval A.","year":"2012","unstructured":"Raval A.; Parmar A.; Raval A.; Bahadur P.; Preparation and optimization of media using Pluronic\u00ae micelles for solubilization of sirolimus and release from the drug eluting stents. Colloids Surf B Biointerfaces 2012,93,180-187","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jddst.2019.03.015","volume":"51","author":"Lv P.","year":"2019","unstructured":"Lv P.; Zhang D.; Guo M.; Liu J.; Chen X.; Guo R.; Xu Y.; Zhang Q.; Liu Y.; Guo H.; Yang M.; Structural analysis and cytotoxicity of host-guest inclusion complexes of cannabidiol with three native cyclodextrins. J Drug Deliv Sci Technol 2019,51,337-344","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00204-020-02689-3","volume":"94","year":"2020","unstructured":"Gulcin, \u0130. Antioxidants and antioxidant methods: An updated overview. Arch Toxicol 2020,94(3),651-715","journal-title":"Arch Toxicol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/coatings11010003","volume":"11","author":"Volmajer Valh J.","year":"2020","unstructured":"Volmajer Valh J.; Per\u0161in Z.; Von\u010dina, B.; Vrezner, K.; Tu\u0161ek, L.; Fras Zemlji\u010d L. Microencapsulation of cannabidiol in liposomes as coating for cellulose for potential advanced sanitary material. Coatings 2020,11(1),3","journal-title":"Coatings"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1039\/C9AN00890J","volume":"144","author":"Hacke A.C.M.","year":"2019","unstructured":"Hacke A.C.M.; Lima D.; de Costa F.; Deshmukh K.; Li N.; Chow A.M.; Marques J.A.; Pereira R.P.; Kerman K.; Probing the antioxidant activity of \u0394 9 -tetrahydrocannabinol and cannabidiol in Cannabis sativa extracts. Analyst (Lond) 2019,144(16),4952-4961","journal-title":"Analyst (Lond)"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230330090025","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215174\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230330090025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T08:58:42Z","timestamp":1698829122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215174\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230330090025","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}